Datasheet | July 14, 2019

Product Characterization Assay Package - Impurities

Source: MilliporeSigma

Many different impurities are present in or generated during the mAb manufacturing process. We work to make sure your biotherapy’s development program isn’t derailed by process or product contaminates that can arise from raw input materials, occur as residual processing agents, or formed as reaction by-products. We have years of experience with routine to high complexity assays for both R&D and GMP purposes to support data requirements at every phase of the development cycle. With state-of-the-art instrumentation, fast turnaround times, and subject matter experts available for consultation, we provide reliable results to push your project forward.